Table: SymBio Pharmaceuticals - 9-MTH group results

SymBio Pharmaceuticals

08/11/2022 06:30

Nov 8 (Reuters)- 
             SymBio Pharmaceuticals Limited 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Sep 30, 2022        Sep 30, 2021     Dec 31, 2022 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               7.36                                 10.00    
  Operating           1.59                                  2.00    
  Recurring           1.84                                  2.30    
  Net                 1.56                                  1.65    
  EPS               40.00 yen                            42.42 yen  
  EPS Diluted       39.43 yen                                       
  Ann Div                                  NIL              NIL     
  -Q2 div              NIL                 NIL                      
  -Q4 div                                  NIL              NIL     
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T